Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)

N/ACompletedNCT03212053

Hospices Civils de Lyon51 enrolled

Overview

There is no prospective study published on the Essential Thrombocythemia and the correlation between this specific disease, its complications and the biological variations observed. The aim of this study is to demonstrate a correlation between biological tests of haemostasis, as Multiplate analyser and thromboelastometry (ROTEM) and the occurrence of clinical complications, thrombosis and/or haemorrhage, in order to determine if this biological tests could be biological prognostic factors

Study Type

INTERVENTIONAL

Allocation

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

Thrombocythemia Essential

Interventions

biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Patients will have blood samples at each consultation (2 or 3 sampling tubes) in order to carry out systematically three biological tests

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult aged more than 18 years old * Patient followed in consultation for an Essential Thrombocythemia at diagnosis or during the follow-up * Collection of the informed consent * Patient affiliated to Social Security Exclusion Criteria: * Patients aged less than 18 years old * Refusal of signature of the informed consent * Patients under guardianship

Locations (1)

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

Outcomes

Primary Outcomes

Occurrence of thrombotic complications

All thrombotic complications will be gathered by the investigators during the four months following the realization of Multiplate and ROTEM test